Zhejiang Huahai Pharmaceutical Co., Ltd.

This study tested a new drug, levomilnacipran, for treating major depression. It involved 392 adults aged 18 to 65 with moderate to severe depression. The drug was compared to duloxetine, a commonly used antidepressant, over 8 weeks to see how well it eased symptoms and if it was…